Reprogramming Transcriptional Networks via CREB1 Lactylation at K122 Activates HMGB1-Mediated NETosis and Chemoresistance

Jia-Mei Wang, Fu-Ying Zhao, Qi Zhang, Ye Yuan, Bai-Qiang Li, Ning Liu, Jing-Jie Li, Chuan Liu, Hua-Qin Wang · 2026

Read Reprogramming Transcriptional Networks via CREB1 Lactylation at K122 Activates HMGB1-Mediated NETosis and Chemoresistance by Jia-Mei Wang, Fu-Ying Zhao, Qi Zhang, Ye Yuan, Bai-Qiang Li, Ning Liu, Jing-Jie Li, Chuan Liu, Hua-Qin Wang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13215458.txt.

Description

Jia-Mei Wang and co-authors identify a chemical mark on a gene regulator as a driver of drug resistance in ovarian cancer, published in 2026. Resistance to the drug cisplatin is a major obstacle in treating this cancer. Tumors rich in lactate, a metabolic byproduct, tend to resist the drug, but the role of a lactate-based protein mark was unclear.

Using a proteome-wide scan for the mark, the team found one site on the regulator CREB1 that was heavily marked in resistant cells and patient tissue. Adding the mark is done by one enzyme and removed by another. A mutant that mimics the mark made cells resist the drug and tumors grow, while a mutant that blocks it made cells sensitive. The mark also rewired which genes the regulator switches on.

Catalog record

CREATORJia-Mei Wang, Fu-Ying Zhao, Qi Zhang, Ye Yuan, Bai-Qiang Li, Ning Liu, Jing-Jie Li, Chuan Liu, Hua-Qin Wang
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE64 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13215458

Browse the full library · About the Tower of Babel